Carl A. Merton Purchases 26,000 Shares of Tilray Inc (NASDAQ:TLRY) Stock

Tilray Inc (NASDAQ:TLRY) CFO Carl A. Merton purchased 26,000 shares of Tilray stock in a transaction that occurred on Friday, November 15th. The shares were bought at an average price of $1.36 per share, with a total value of $35,360.00. Following the transaction, the chief financial officer now owns 26,000 shares of the company’s stock, valued at $35,360. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Tilray Trading Down 1.5 %

Shares of NASDAQ:TLRY opened at $1.29 on Thursday. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The company has a 50-day moving average price of $1.63 and a two-hundred day moving average price of $1.75. Tilray Inc has a twelve month low of $1.28 and a twelve month high of $2.97.

Tilray (NASDAQ:TLRY) last issued its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business had revenue of $200.00 million for the quarter, compared to analysts’ expectations of $218.70 million. During the same quarter in the previous year, the firm posted ($0.10) EPS. The business’s revenue for the quarter was up 13.0% compared to the same quarter last year. On average, equities analysts predict that Tilray Inc will post -0.14 EPS for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Tidal Investments LLC lifted its holdings in shares of Tilray by 36,687.0% in the first quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock worth $26,373,000 after buying an additional 10,648,403 shares in the last quarter. BNP Paribas Financial Markets boosted its stake in Tilray by 1,314.1% during the third quarter. BNP Paribas Financial Markets now owns 1,819,494 shares of the company’s stock valued at $3,202,000 after buying an additional 1,690,827 shares during the period. Point72 Asset Management L.P. purchased a new position in Tilray during the third quarter worth about $1,348,000. Bank of Montreal Can raised its holdings in shares of Tilray by 19.6% in the 2nd quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after acquiring an additional 355,778 shares in the last quarter. Finally, XTX Topco Ltd boosted its position in shares of Tilray by 1,079.7% during the 3rd quarter. XTX Topco Ltd now owns 281,504 shares of the company’s stock valued at $495,000 after acquiring an additional 257,641 shares during the last quarter. Institutional investors own 9.35% of the company’s stock.

Analysts Set New Price Targets

Separately, Roth Mkm lowered their price target on shares of Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a report on Friday, October 11th.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.